Published in Health Risk Factor Week, April 24th, 2007
This trend article about Seoul National University, South Korea, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Current study results from the report, "The effect of thalidomide on spinal cord ischemia/reperfusion injury in a rabbit model," have been published. "Randomized study. To evaluate the effects of thalidomide on spinal cord ischemia/reperfusion injury via reduced TNF-alpha production. Animal experimental laboratory, Clinical Research Institute of Seoul National University Hospital, Seoul, Korea," scientists in Seoul,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.